Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
J Dermatol. 2021 Oct;48(10):1499-1510. doi: 10.1111/1346-8138.15972. Epub 2021 Jun 1.
Comprehensive studies of primary cutaneous extranodal natural killer/T-cell lymphoma (PCENKTL) are scarce. The objectives of this study are to describe PCENKTL in terms of its clinical features, histopathology, immunophenotypes, and prognosis, and to analyze factors affecting patient survival outcomes. We searched four databases and include studies with extractable data. We also searched the Asan Medical Center database for cases of PCENKTL. We include a total of 289 patients. The mean age at diagnosis was 52.8 years and the female to male ratio was 1:1.2. The most common clinical morphology was a subcutaneous nodule, followed by ulceration. About half of the patients presented with disseminated skin lesions. The median overall survival was 12.0 months and the 5-year survival rate was 22.0%. There was no correlation between the clinical morphology or the histopathological features of the skin lesions with the patient outcomes. Advanced TNM stage, a disseminated skin lesion, tumor location on the leg or trunk, the presence of B symptoms, and a high International Prognostic Index score were associated with a worse prognosis, and chemoradiotherapy was associated with a better survival outcome as compared with chemotherapy alone in univariable analyses. In multivariable analyses, only advanced TNM stage and tumor location on the leg were associated with a worse prognosis. In conclusion, PCENKTL is an aggressive cutaneous lymphoma and its prognosis is associated with TNM stage and tumor location.
原发性皮肤结外自然杀伤/T 细胞淋巴瘤(PCENKTL)的综合研究较为匮乏。本研究旨在描述 PCENKTL 的临床特征、组织病理学、免疫表型和预后,并分析影响患者生存结局的因素。我们检索了四个数据库并纳入了可提取数据的研究,同时还检索了 Asan 医疗中心的 PCENKTL 病例数据库。共纳入 289 例患者,诊断时的平均年龄为 52.8 岁,男女比例为 1:1.2。最常见的临床形态是皮下结节,其次是溃疡。约一半的患者表现为弥漫性皮肤病变。中位总生存期为 12.0 个月,5 年生存率为 22.0%。皮肤病变的临床形态或组织病理学特征与患者结局之间无相关性。晚期 TNM 分期、弥漫性皮肤病变、腿部或躯干的肿瘤位置、B 症状和较高的国际预后指数评分与预后较差相关,与单独化疗相比,化疗联合放化疗在单变量分析中与更好的生存结局相关。在多变量分析中,只有晚期 TNM 分期和腿部肿瘤位置与预后较差相关。总之,PCENKTL 是一种侵袭性皮肤淋巴瘤,其预后与 TNM 分期和肿瘤位置有关。